The EFF is a growing multiple stakeholder platform for the exchange and sharing of insights and innovations to drive the future of clinical development in inherited retinal diseases. Organized by ProQR
ProQR will host a virtual Analyst and Investor Event on Wednesday, December 11, 2024 from 10:00 am until approximately 12:30 pm EST, including an Analyst Q&A session with members of the ProQR Management Team.
… functions. Axiomer could potentially yield a new class of innovative medicines and treat currently untreatable … in the lab and play a key role in translating scientific innovation into practical applications. You will …
… functions. Axiomer could potentially yield a new class of innovative medicines and treat currently untreatable … applied clinical quantitative sciences and a passion for innovation in drug development. Location: Leiden, NL Key …